SUPERNOVAStudy Understanding Pre-exposure Prophylaxis of Novel Antibodies
|
ENROLLMENT HAS CLOSED AS OF OCTOBER 2023
The SUPERNOVA Study:
We are researching investigational antibodies that may help to protect people with weaker immunity from contracting COVID-19.
The SUPERNOVA Study is looking at an investigational medication (study drug) to see if it is safe and can help to protect people with an impaired immune system from contracting COVID-19. For more information, click here.
|
Are you able to help?
You may be able to take part in the SUPERNOVA Study if you:
and will have about 11 study center visits. Extra visits may be needed if participants develop COVID-19 symptoms. |
How to participate
Please contact the study team today if you are interested in joining this COVID-19 prevention study
or would like more information. By contacting us, you are under no obligation to take part in the study. We look forward to hearing from you soon.
or would like more information. By contacting us, you are under no obligation to take part in the study. We look forward to hearing from you soon.
Lumi Research
22751 Professional Drive Suite 240 Kingwood, Texas 77339 Office Hours: 9:00am - 5:00pm, Monday - Friday |
Above contents were IRB Approved at the protocol level Mar 10, 2023; 20230073 #36741087.0